ATE482705T1 - Antibakterielle behandlung von osteoarthritis - Google Patents

Antibakterielle behandlung von osteoarthritis

Info

Publication number
ATE482705T1
ATE482705T1 AT02730515T AT02730515T ATE482705T1 AT E482705 T1 ATE482705 T1 AT E482705T1 AT 02730515 T AT02730515 T AT 02730515T AT 02730515 T AT02730515 T AT 02730515T AT E482705 T1 ATE482705 T1 AT E482705T1
Authority
AT
Austria
Prior art keywords
osteoarthritis
antibacterial treatment
treatment
medicament
diagnosis
Prior art date
Application number
AT02730515T
Other languages
English (en)
Inventor
Mohamed El-Gewely
Original Assignee
Orthogenics As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orthogenics As filed Critical Orthogenics As
Application granted granted Critical
Publication of ATE482705T1 publication Critical patent/ATE482705T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT02730515T 2001-06-15 2002-06-17 Antibakterielle behandlung von osteoarthritis ATE482705T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0114672.9A GB0114672D0 (en) 2001-06-15 2001-06-15 Pharmaceutical formulations and methods of medical treatment
PCT/GB2002/002771 WO2002102384A1 (en) 2001-06-15 2002-06-17 Antibacterial treatment of osteoarthritis

Publications (1)

Publication Number Publication Date
ATE482705T1 true ATE482705T1 (de) 2010-10-15

Family

ID=9916704

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02730515T ATE482705T1 (de) 2001-06-15 2002-06-17 Antibakterielle behandlung von osteoarthritis

Country Status (11)

Country Link
US (2) US8318422B2 (de)
EP (1) EP1401448B1 (de)
AT (1) ATE482705T1 (de)
AU (1) AU2002302833B2 (de)
CA (1) CA2456685A1 (de)
DE (1) DE60237821D1 (de)
DK (1) DK1401448T3 (de)
ES (1) ES2349030T3 (de)
GB (1) GB0114672D0 (de)
PT (1) PT1401448E (de)
WO (1) WO2002102384A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0114672D0 (en) * 2001-06-15 2001-08-08 Orthogenics As Pharmaceutical formulations and methods of medical treatment
US8012950B2 (en) * 2003-08-29 2011-09-06 Wisconsin Alumni Research Foundation Method to diagnose and treat degenerative joint disease
US20050148553A1 (en) * 2003-09-05 2005-07-07 Testa Raymond T. Use of tigecycline, alone, or in combination with rifampin to treat osteomyelitis and/or septic arthritis
FI20031927A0 (fi) * 2003-12-31 2003-12-31 Faron Pharmaceuticals Oy Terapeuttisesti vaikuttavia aineita ja niiden käyttö
JP2007068431A (ja) * 2005-09-05 2007-03-22 Oji Paper Co Ltd 細菌叢の解析方法およびキット
US20080045485A1 (en) * 2006-08-17 2008-02-21 Peter Muir Methods of diagnosing synovial disease in a mammal by detecting bacterial DNA in synovial tissues from dogs with inflammatory knee arthritis and degenerative anterior cruciate ligament rupture
WO2012037356A2 (en) * 2010-09-15 2012-03-22 Rush University Medical Center Gene expression profiles and products for the diagnosis and prognosis of post-injury synovitis and osteoarthritis

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5723597A (en) * 1983-01-10 1998-03-03 Gen-Probe Incorporated Ribosomal nucleic acid probes for detecting organisms or groups of organisms
CA2136803A1 (en) 1993-12-22 1995-06-23 Kazumi Ogata Steroid derivatives
EP1036846A3 (de) * 1994-02-28 2000-10-18 Shimadzu Corporation Oligonukleotide und Verfahren zum Nachweis von Bakterien
CA2219277A1 (en) * 1995-05-03 1996-11-07 Pfizer Limited Novel tetracycline derivatives
AUPN771596A0 (en) 1996-01-25 1996-02-15 Mclean, Allan Joseph Methods of and compositions for potentiating the action of agents active on cell-wall sites of susceptible bacteria
CA2223006A1 (en) * 1996-04-03 1997-10-09 Kyowa Hakko Kogyo Co., Ltd. Physiologically active substance ei-2128-1
US5789395A (en) * 1996-08-30 1998-08-04 The Research Foundation Of State University Of New York Method of using tetracycline compounds for inhibition of endogenous nitric oxide production
GB2375488B (en) 2001-05-18 2004-09-15 Sarkis Tokatlian Sub aqua breathing system
GB0114672D0 (en) * 2001-06-15 2001-08-08 Orthogenics As Pharmaceutical formulations and methods of medical treatment

Also Published As

Publication number Publication date
AU2002302833B2 (en) 2007-05-17
US20040236074A1 (en) 2004-11-25
WO2002102384A1 (en) 2002-12-27
GB0114672D0 (en) 2001-08-08
ES2349030T3 (es) 2010-12-22
US20080027013A1 (en) 2008-01-31
CA2456685A1 (en) 2002-12-27
DE60237821D1 (de) 2010-11-11
EP1401448B1 (de) 2010-09-29
US8318422B2 (en) 2012-11-27
PT1401448E (pt) 2010-10-27
EP1401448A1 (de) 2004-03-31
DK1401448T3 (da) 2010-12-13
US8349816B2 (en) 2013-01-08

Similar Documents

Publication Publication Date Title
CY1115117T1 (el) Παραγωγα υποκατεστημενων οξαζολιδινονων και η χρηση τους ως αναστολεις παραγοντα χα
ATE397930T1 (de) Verwendung von oxazolidinon-chinolin-hybrid- antibiotika zur behandlung von anthrax und anderen infektionen
ATE468137T1 (de) Inhibitoren von hmgb1 zur behandlung von gewebekrankheiten
DE50311898D1 (de) Fredericamycin-derivate als arzneimittel zur tumorbehandlung
PT1164135E (pt) Metal-ftalocianinas substituidas sua preparacao e utilizacao
SG162614A1 (en) Bicyclic 6-alkylidene-penems as beta-lactamases inhibitors
ATE258057T1 (de) Therapeutische und diagnostische agenzien zur behandlung mikrobieller infektionen
EA200600374A1 (ru) Замещённые пиперидинофенилоксазолидиноны, обладающие противомикробной активностью, с повышенной in vivo эффективностью
ATE479430T1 (de) Verwendung von retinoid-typ verbindungen als antibakterielle mittel gegen staphylococcus aureus
ATE482705T1 (de) Antibakterielle behandlung von osteoarthritis
ATE372986T1 (de) N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridon s als antimikrobielle mittel
NO20044550L (no) Heterotrisyklyl 6-alkaliden-penemer som beta-laktamaseinhibitorer
EA200601238A1 (ru) Медикаменты для профилактики и лечения бромидроза и для улучшения запаха тела
NO20032406D0 (no) Anvendelse av 1-fenyl-3-dimetylaminopropanforbindelser for behandling av urininkontinens
EA200200853A1 (ru) Применение 2-метилтиазолидин-3,3-дикарбоновой кислоты (2-мтдк) и/или ее физиологически совместимых солей для лечения и/или предупреждения рака
CY1105142T1 (el) Χρηση υποκατεστημενων ενωσεων 6-διμεθυλαμινομεθυλο-1-φαινυλο-κυκλοεξανιου για τη θepαπεια της ακρατειας ουρων
CY1105317T1 (el) Χρηση υποκατεστημενων ενωσεων 6-διμεθυλαμινομεθυλο-1-φαινυλο-κυκλοεξανιου για τη θepαπεια της ακρατειας ουρων
DE60114778D1 (de) Behandlung von infektionen in tieren
DE502006004735D1 (de) Mittel zur behandlung von infektionen
DE60305018D1 (de) Citalopram zur behandlung von bluthochdruck
MY140520A (en) TRICYCLIC 6-ALKYLIDE-PENEMS AS ß-LACTAMASE INHIBITORS
ATE506946T1 (de) Verbindung zur prävention und behandlung von linksventrikulärer hypertrophie bei dialyse- patienten
MY140242A (en) BICYCLIC 6-ALKYLIDENE-PENEMS AS ß-LACTAMASES INHIBITORS
UY26502A1 (es) Oxazolidinonas substituidas y su uso
UA37830A (uk) Засіб "аспамгран" для лікування застудних та респіраторно-інфекційних захворювань

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1401448

Country of ref document: EP